Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease
Christopher-Stine, L.; Wigley, F.
Journal of Rheumatology 30(12): 2725-2727
2003
ISSN/ISBN: 0315-162X PMID: 14719225 Document Number: 554030
Document emailed within 1 workday
Related Documents
Dupond, J.L.; Humbert, P.; Mantion, G.; Gillet, M.; Billerey, C.; Mallet, H. 1988: Mixed connective tissue disease with severe esophageal sclerodermic involvement without systemic scleroderma. An unusual form of the overlap syndrome Revue du Rhumatisme et des Maladies Osteo-Articulaires 55(12): 1015-1017Nishimaki, T. 1999: Mixed connective tissue disease and overlap syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 57(2): 355-359
Parker, M.D. 1973: Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease Journal of Laboratory and Clinical Medicine 82(5): 769-775
Pepmueller, P.H. 2016: Undifferentiated Connective Tissue Disease, Mixed Connective Tissue Disease, and Overlap Syndromes in Rheumatology Missouri Medicine 113(2): 136-140
Brandt, J.; Maier, T.; Rudwaleit, M.; Kühl, U.; Hiepe, F.; Sieper, J.; Braun, J. 2002: Co-occurrence of spondyloarthropathy and connective tissue disease: development of Sjögren's syndrome and mixed connective tissue disease (MCTD) in a patient with ankylosing spondylitis Clinical and Experimental Rheumatology 20(1): 80-84
Krichevskaia, O.A.; Kliukvina, N.G.; Aleksandrova, E.N.; Samsonov, M.I.; Nasonov, E.L. 2004: Clinical value of soluble tumor necrosis factor-alpha receptors in patients with systemic lupus erythematosus Klinicheskaia Meditsina 82(10): 51-55
Vallera, D.A.; Taylor, P.A.; Vannice, J.L.; Panoskaltsis-Mortari, A.; Blazar, B.R. 1995: Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice Transplantation 60(11): 1371-1374
Weber, P.; Ganser, G.; Frosch, M.; Roth, J.; Hülskamp, G.; Zimmer, K.P. 2000: Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease Journal of Rheumatology 27(11): 2692-2695
Goldfeld, A.E.; Birch-Limberger, K.; Schooley, R.T.; Walker, B.D. 1991: HIV-1 infection does not induce tumor necrosis factor-alpha or interferon-beta gene transcription Journal of Acquired Immune Deficiency Syndromes 4(1): 41-47
Kaneko, H.; Yamada, H.; Mizuno, S.; Udagawa, T.; Kazumi, Y.; Sekikawa, K.; Sugawara, I. 1999: Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice Laboratory Investigation; a Journal of Technical Methods and Pathology 79(4): 379-386
Bélec, L.; Meillet, D.; Grésenguet, G.; Gherardi, R.K. 1995: Increased tumor necrosis factor-alpha serum levels in patients with HIV wasting syndrome and euthyroid sick syndrome Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 8(2): 212-214
Bélec, L.; Meillet, D.; Grésenguet, G.; Gherardi, R.K. 1995: Increased tumor necrosis factor-alpha serum levels in patients with HIV wasting syndrome and euthyroid sick syndrome Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 8(2): 212-214
Sönnichsen, N.; Ziegler, H.; Barthelmes, H.; Albrecht-Nebe, H.; Schulze, P.; Brenke, A. 1988: Mixed connective tissue disease (Sharp). Nosologic entity or a subgroup of systemic lupus erythematosus? Dermatologische Monatschrift 174(3): 137-141
Maury, C.P.; Salo, E.; Pelkonen, P. 1989: Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease Journal of Laboratory and Clinical Medicine 113(5): 651-654
Meng, Z.H.; Hudson, A.P.; Schumacher, H.R.; Baker, J.F.; Baker, D.G. 1997: Monosodium urate, hydroxyapatite, and calcium pyrophosphate crystals induce tumor necrosis factor-alpha expression in a mononuclear cell line Journal of Rheumatology 24(12): 2385-2388
Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653
Whicher, J.T.; Gilbert, A.M.; Westacott, C.; Hutton, C.; Dieppe, P.A. 1986: Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65(1): 80-89
Tanaka, M.; Suzuki, T. 1987: Sicca syndrome in mixed connective tissue disease Ryumachi 27(4): 272-276
Lilbaek, K. 1984: Severe nephrotic syndrome in mixed connective tissue disease Ugeskrift for Laeger 146(11): 815-816